Trials / Completed
CompletedNCT01913379
Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole
A Phase I Randomized, Open-label, 3-arm Parallel-design Study to Determine the Effect of Multiple-dose Gemfibrozil or Itraconazole on the Pharmacokinetics, Safety and Tolerability of Single-dose MDV3100 (ASP9785) in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Astellas Pharma Europe B.V. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A study to assess possible drug-drug interactions between MDV3100 and gemfibrozil and MDV3100 and Itraconazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MDV3100 | Oral |
| DRUG | Gemfibrozil | Oral |
| DRUG | Itraconazole | Oral |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2013-08-01
- Last updated
- 2013-08-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01913379. Inclusion in this directory is not an endorsement.